PORTLAND, Ore., Feb. 7 /PRNewswire-FirstCall/ --
Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of
needle-free drug delivery systems, announced today that Company management
will make a presentation to analysts and portfolio managers at The Wall Street
Analyst Forum's Institutional Investor Conference in New York City on
Thursday, February 14, 2002 at 10:50 a.m. Eastern Standard Time.
Approximately 100 public companies will be presenting at the Conference from
February 11, 2002 through February 14, 2002. Analysts and portfolio managers
who wish to attend the presentation should contact The Wall Street Analyst
Forum at 802-253-7596 to request additional information.
Investors may also access an Internet web cast of the presentation at:
http://media.corporate-ir.net/media_files/priv/wsaf/event/021102.htm .
About Bioject
Bioject Medical Technologies Inc., based in Portland, Oregon, is an
innovative developer and manufacturer of needle-free drug delivery systems.
Bioject's strategic partners include Amgen, Serono and Alkermes. Needle-free
injection works by forcing medication at high speed through a tiny orifice
held against the skin. This creates a fine stream of high-pressure fluid
penetrating the skin and depositing medication in the tissue beneath.
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks, uncertainties and other factors
that may cause the actual results, performance or achievements of the company,
or industry results, to be materially different from any future results,
performance, or achievements expressed or implied by such forward-looking
statements. Readers of this press release are referred to the Company's
filings with the Securities and Exchange Commission, including the Company's
reports on Forms 10-K and Forms 10-Q for further discussions of factors that
could affect future results. Forward-looking statements are based on the
estimates and opinions of management on the date the statements are made. The
Company assumes no obligation to update forward-looking statements if
conditions or management's estimates or opinions should change.
For more information on Bioject, visit http://www.bioject.com.
SOURCE Bioject Medical Technologies Inc.
 back to top
Related links:
http://www.bioject.com
CONTACT:
Cecelia C. Heer, Investor Relations Manager
of Bioject Medical Technologies Inc., +1-973-605-8554, or
cheer@bioject.com; or Jim Flanagan, IR Strategic Advisors, for
IR/Media, +1-781-863-1333, or jflanagan@iradvisors.com, for
Bioject Medical Technologies Inc.
|
